SN4
SHORT NOTE
5M
★ High-yield
Describe vancomycin and the other drugs used against MRSA and resistant gram-positive organisms.
Vancomycin
Vancomycin is a glycopeptide that binds the D-alanyl-D-alanine terminus of the peptidoglycan precursor, preventing its incorporation and cross-linking. It is bactericidal and acts only on gram-positive organisms.
- Gram-negatives are intrinsically resistant, because the molecule is too large to cross the outer membrane
- Not absorbed orally — which is exactly why oral vancomycin is used for clostridioides difficile colitis, where it acts in the gut lumen; systemic infection requires intravenous administration
- Excreted unchanged by the kidney; the dose must be adjusted and levels monitored
- Time-dependent killing — efficacy relates to trough level and total exposure
| Adverse effect | Details |
|---|---|
| "red man" syndrome | Flushing, erythema and pruritus of the face, neck and upper trunk, with hypotension, during rapid infusion. It is direct histamine release, not an allergy — managed by slowing the infusion (over at least 60 minutes) and antihistamine pretreatment, and does not preclude further use |
| Nephrotoxicity | Especially with aminoglycosides or piperacillin-tazobactam |
| Ototoxicity | Uncommon with modern preparations |
| Neutropenia, thrombophlebitis | With prolonged use |
CLINICAL PEARL
Red man syndrome is an infusion-rate problem, not an allergy, and the distinction matters. Labelling the patient allergic to vancomycin removes one of very few options for MRSA. The correct response is to slow the infusion and premedicate — not to abandon the drug.
Drugs for Mrsa and Resistant Gram-positives
| Drug | Mechanism and features |
|---|---|
| Vancomycin | The standard agent; intravenous for systemic infection |
| Teicoplanin | Similar; longer half-life allowing once-daily dosing, and can be given intramuscularly |
| Linezolid | Oxazolidinone; binds the 50S subunit and prevents initiation. Excellent oral bioavailability (about 100%), so it allows oral treatment of serious infection. Causes reversible myelosuppression with prolonged use (over 2 weeks), peripheral and optic neuropathy, and is a weak MAO inhibitor — risking serotonin syndrome with SSRIs and a tyramine reaction |
| Daptomycin | Lipopeptide; disrupts the membrane. Inactivated BY pulmonary surfactant, so it cannot be used for pneumonia. Causes myopathy — creatine kinase must be monitored |
| Clindamycin, co-trimoxazole, doxycycline | Useful oral options for community-acquired MRSA skin infection |
| Ceftaroline | The fifth-generation cephalosporin with MRSA activity |
| Tigecycline | Broad, including MRSA and VRE; poor blood levels, so it is unsuitable for bacteraemia; associated with increased mortality in some trials |
| Mupirocin | Topical; nasal decolonisation of MRSA carriers |
Clindamycin and Metronidazole for Anaerobes
- Clindamycin — binds the 50S subunit; active against gram-positive cocci and anaerobes above the diaphragm; excellent bone and abscess penetration. It inhibits toxin production, which is why it is added in necrotising fasciitis and toxic shock syndrome. The classical cause of clostridioides difficile colitis
- Metronidazole — a prodrug reduced to a cytotoxic intermediate only in anaerobic conditions, which is the basis of its selectivity; active against anaerobes below the diaphragm and against protozoa (amoebiasis, giardiasis, trichomoniasis). Causes a metallic taste, nausea, peripheral neuropathy with prolonged use, and a disulfiram-like reaction with alcohol
Applied Aspects
- Monitor vancomycin trough levels and renal function; under-dosing is as much a problem as toxicity and leads to treatment failure and resistance
- Oral vancomycin for C. Difficile, intravenous for everything else — the routes are not interchangeable, and giving intravenous vancomycin for colitis does not work
- Linezolid allows oral treatment of serious resistant infection, which can avoid prolonged hospital stay — a real advantage where beds and intravenous access are limited
- Never use daptomycin for pneumonia
- Warn patients on metronidazole to avoid alcohol during and for 48 hours after the course
- MRSA rates in Indian hospitals are high, and infection control — hand hygiene, screening and decolonisation — matters more than the availability of any particular drug
All questions in Antimicrobials: General & Antibacterials
- Q1Describe the general principles of antimicrobial therapy including selective toxicity, classification, pharmacodynamic patterns and combination therapy. ★
- Q2Classify penicillins. Describe their mechanism of action, pharmacokinetics, uses and adverse effects. ★
- Q3Classify cephalosporins by generation. Describe the other beta-lactams and their uses and adverse effects. ★
- Q4Describe the aminoglycosides and macrolides with their mechanisms, uses and toxicity. ★
- Q5Describe the mechanisms of antimicrobial resistance, its spread and the principles of antimicrobial stewardship. ★
- SN1Describe the fluoroquinolones with their classification, uses and adverse effects. ★
- SN2Describe the tetracyclines and chloramphenicol with their uses and adverse effects. ★
- SN3Describe the sulphonamides and trimethoprim. Explain the basis of their synergy and the uses of co-trimoxazole. ★
- SN4Describe vancomycin and the other drugs used against MRSA and resistant gram-positive organisms. ★
- SN5Define chemoprophylaxis. Describe the principles of surgical and medical antimicrobial prophylaxis. ★
- SN6Define superinfection. Describe Clostridioides difficile colitis and its management. ★
- SN7Classify antiseptics and disinfectants. Describe the important agents and the factors affecting their activity.